Tang Capital Management as of Sept. 30, 2012
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 23 positions in its portfolio as reported in the September 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pdl Biopharma Inc cnv | 17.7 | $50M | 38M | 1.34 | |
| Mannkind Corp note 3.750%12/1 | 9.1 | $26M | 42M | 0.62 | |
| Nektar Therapeutics (NKTR) | 8.3 | $24M | 2.2M | 10.68 | |
| Affymax (AFFY) | 6.7 | $19M | 900k | 21.06 | |
| Spectrum Pharmaceuticals | 6.4 | $18M | 1.6M | 11.70 | |
| Dendreon Corp note | 6.1 | $17M | 27M | 0.65 | |
| DepoMed | 5.7 | $16M | 2.7M | 5.91 | |
| D Horizon Pharma | 5.2 | $15M | 4.2M | 3.50 | |
| Intermune Inc note 2.500% 9/1 | 4.7 | $13M | 17M | 0.79 | |
| Salix Pharmaceuticals | 4.5 | $13M | 300k | 42.34 | |
| OncoGenex Pharmaceuticals | 4.2 | $12M | 833k | 14.17 | |
| Vanda Pharmaceuticals (VNDA) | 3.4 | $9.7M | 2.4M | 4.03 | |
| Savient Pharmaceuticals note | 3.3 | $9.3M | 37M | 0.25 | |
| Biomarin Pharmaceutical Inc bond cv | 2.5 | $7.0M | 3.0M | 2.32 | |
| Transcept Pharmaceuticals | 2.3 | $6.4M | 1.2M | 5.31 | |
| Anthera Pharmaceuticals | 1.9 | $5.4M | 5.5M | 0.99 | |
| Oncothyreon | 1.8 | $5.1M | 1.0M | 5.13 | |
| Endocyte | 1.6 | $4.6M | 466k | 9.97 | |
| MannKind Corporation | 1.6 | $4.5M | 1.6M | 2.88 | |
| Neoprobe | 1.5 | $4.3M | 1.6M | 2.75 | |
| Dendreon Corp cnv | 1.3 | $3.8M | 4.0M | 0.94 | |
| Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.3 | $890k | 278k | 3.20 | |
| Dendreon Corporation | 0.1 | $383k | 80k | 4.81 |
